Literature DB >> 2000697

Thyroid volume and goitre prevalence in the elderly as determined by ultrasound and their relationships to laboratory indices.

G Hintze1, J Windeler, J Baumert, H Stein, J Köbberling.   

Abstract

In 569 unselected elderly subjects over 60 years from the general population of an iodine-deficient area, a palpation and an ultrasound investigation of the thyroid were performed. Additionally, thyroid hormone values were determined in 466 of the 569 subjects (81.9%) and urinary iodine excretion in 491 subjects (86.3%). By palpation, no thyroid enlargement was noticed in 302 subjects (54.2%), goitre Ia in 98 (17.6%), goitre Ib in 94 (16.9%), goitre II in 53 (9.5%), and goitre III in 10 (1.8%). The thyroid volumes (medians) by ultrasound were 18.6 ml in the entire group, in women (N = 489) 19.2 ml, and in men (N = 80) 16.6 ml. One hundred and one subjects had a thyroid nodule (17.6%), 43 persons cystic lesions (7.6%). If, according to the literature, a goitre is defined as a thyroid enlargement of more than 18 ml in women and more than 25 ml in males, a goitre prevalence of 54.2% in females and of 22.5% in males was obtained. The goitre prevalence in the entire group was calculated as 49.7%. Thyroid hormone measurements showed in subjects with goitre a significant lower TSH value (p less than 0.001) and a higher thyroglobulin value (p less than 0.001). In summary, the study shows a high prevalence of goitre in elderly subjects, a high prevalence of nodules in these thyroids, a negative correlation of goitre volume with TSH, and a positive correlation of goitre volume with the thyroglobulin concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000697     DOI: 10.1530/acta.0.1240012

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

Review 1.  Thyroglobulin as a biomarker of iodine deficiency: a review.

Authors:  Zheng Feei Ma; Sheila A Skeaff
Journal:  Thyroid       Date:  2014-06-12       Impact factor: 6.568

2.  Sonomorphologic evaluation of goiter in an iodine deficiency area in the Ivory Coast.

Authors:  D Franke; G Filler; M Zivicnjak; P Kouamé; I Ohde; L Eckhardt; E Doehring; J H Ehrich
Journal:  Am J Public Health       Date:  1999-12       Impact factor: 9.308

3.  Thyroid function in elderly people. Take account of iodine supply.

Authors:  I Szabolcs; M Góth; L Kovács; O Dohán; G Szilágyi
Journal:  BMJ       Date:  1993-09-18

4.  Study of an endemic goiter area in northern Campania.

Authors:  M Iodice; A Arnese; M Colapietro; S De Riu; E Prospero; G Sagliocco; R Ullucci; G M Grasso
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

5.  Evaluation of goiter endemia by ultrasound in schoolchildren in Val Sarmento (Italy).

Authors:  G Lupoli; D Russo; M R Fittipaldi; G Vitale; A Napodano; A Pagliuca; V Nuzzo; F Fonderico; E Rampone; E Cascone; A Nasti; V Macchia
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

6.  Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.

Authors:  Lindsay Hargitai; Stephanie Strobl; Oskar Koperek; Susanne Urach; Wolfgang Raber; Anton Staudenherz; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2020-04

7.  Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.

Authors:  Krzysztof Kaliszewski; Dorota Diakowska; Beata Wojtczak; Marta Strutyńska-Karpińska; Paweł Domosławski; Krzysztof Sutkowski; Mateusz Głód; Waldemar Balcerzak; Zdzisław Forkasiewicz; Tadeusz Łukieńczuk
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

8.  Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake.

Authors:  Zhaojun Wang; Hanyi Zhang; Xiaowen Zhang; Jie Sun; Cheng Han; Chenyan Li; Yongze Li; Xiaochun Teng; Chenling Fan; Aihua Liu; Zhongyan Shan; Chao Liu; Jianping Weng; Weiping Teng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.